To provide capital appreciation, investing in an actively managed portfolio of mainly European equities.
Name | % Net Assets |
---|---|
TOTAL S.A | 4.0% |
NOVARTIS AG | 3.9% |
ROCHE HLDG AG | 2.9% |
SANOFI-AVENTIS | 2.8% |
FRANCE TELECOM | 2.8% |
NESTLE SA | 2.6% |
TELEFONICA SA | 2.3% |
VIVENDI | 2.2% |
E.ON AG | 1.8% |
KONINKLIJKE AHOLD NV | 1.8% |
Key | % Net Assets |
---|---|
TOTAL S.A | 4.0% |
NOVARTIS AG | 3.9% |
ROCHE HLDG AG | 2.9% |
SANOFI-AVENTIS | 2.8% |
Other | 86.4% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/03/2004 |
---|---|
Fund Manager | Acadian / Clay Finlay |
TER | 1.99 (30-Sep-2009) |
Minimum Investment | |
---|---|
Initial | 500 |
Additional | n/a |
Savings | 50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.85% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.08 |
You are here: research